Development of residency program guidelines for interaction with the pharmaceutical industry

Medical residency programs are likely to face increasing pressure to address their relations with the pharmaceutical industry. Our internal medicine residency program has developed guidelines that were adopted after extensive debate by residents and faculty members. The guidelines are based on the p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Canadian Medical Association journal (CMAJ) 1993-08, Vol.149 (4), p.405
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page 405
container_title Canadian Medical Association journal (CMAJ)
container_volume 149
description Medical residency programs are likely to face increasing pressure to address their relations with the pharmaceutical industry. Our internal medicine residency program has developed guidelines that were adopted after extensive debate by residents and faculty members. The guidelines are based on the principles that residents and faculty should set the educational agenda and that the residency program should not allow gifts of any sort from industry to residents. Specific policies include obtaining and screening educational materials from the industry before residents are exposed to them, proscribing "drug lunches" and accepting industry sponsorship only when the residency program maintains complete control of the educational event being sponsored. The industry response to the guidelines was split; about half reacted negatively, and half found the guidelines acceptable. Our experience suggests that productive debate about guidelines for the interaction of residency programs with the pharmaceutical industry is possible and desirable and that explicit policies can clarify areas of ambiguity.
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_204787686</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>450577461</sourcerecordid><originalsourceid>FETCH-LOGICAL-p180t-dfa8a129d3bfa2cb7c48f5e08bd51fd59d53613b8bca1f3d9845035c51e16e363</originalsourceid><addsrcrecordid>eNotjk1LxDAYhIMoWFf_Q_BeyEeTpkdZP2HBi96EJU3ebLO0SU1SZf-9BXcuA8PDzFygijZK1Yyz7hJVRDFS866R1-gm5yNZxVlboa9H-IExzhOEgqPDCbK3EMwJzykekp7wYVmD0QfI2MWEfSiQtCk-Bvzry4DLAHgedJq0gaV4o8eVsUsu6XSLrpweM9ydfYM-n58-tq_17v3lbfuwq2eqSKmt00pT1lneO81M35pGOQFE9VZQZ0VnBZeU96o3mjpuO9UIwoURFKgELvkG3f_3rp-_F8hlf4xLCuvknpGmVa1Ukv8BhFRSUA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204787686</pqid></control><display><type>article</type><title>Development of residency program guidelines for interaction with the pharmaceutical industry</title><source>PubMed Central</source><source>Alma/SFX Local Collection</source><description>Medical residency programs are likely to face increasing pressure to address their relations with the pharmaceutical industry. Our internal medicine residency program has developed guidelines that were adopted after extensive debate by residents and faculty members. The guidelines are based on the principles that residents and faculty should set the educational agenda and that the residency program should not allow gifts of any sort from industry to residents. Specific policies include obtaining and screening educational materials from the industry before residents are exposed to them, proscribing "drug lunches" and accepting industry sponsorship only when the residency program maintains complete control of the educational event being sponsored. The industry response to the guidelines was split; about half reacted negatively, and half found the guidelines acceptable. Our experience suggests that productive debate about guidelines for the interaction of residency programs with the pharmaceutical industry is possible and desirable and that explicit policies can clarify areas of ambiguity.</description><identifier>ISSN: 0820-3946</identifier><identifier>EISSN: 1488-2329</identifier><identifier>CODEN: CMAJAX</identifier><language>eng</language><publisher>Ottawa: CMA Impact, Inc</publisher><subject>Medical personnel ; Medicine ; Pharmaceutical industry ; Physician relations ; Public health ; Study &amp; teaching ; Training</subject><ispartof>Canadian Medical Association journal (CMAJ), 1993-08, Vol.149 (4), p.405</ispartof><rights>Copyright Canadian Medical Association Aug 15, 1993</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782</link.rule.ids></links><search><title>Development of residency program guidelines for interaction with the pharmaceutical industry</title><title>Canadian Medical Association journal (CMAJ)</title><description>Medical residency programs are likely to face increasing pressure to address their relations with the pharmaceutical industry. Our internal medicine residency program has developed guidelines that were adopted after extensive debate by residents and faculty members. The guidelines are based on the principles that residents and faculty should set the educational agenda and that the residency program should not allow gifts of any sort from industry to residents. Specific policies include obtaining and screening educational materials from the industry before residents are exposed to them, proscribing "drug lunches" and accepting industry sponsorship only when the residency program maintains complete control of the educational event being sponsored. The industry response to the guidelines was split; about half reacted negatively, and half found the guidelines acceptable. Our experience suggests that productive debate about guidelines for the interaction of residency programs with the pharmaceutical industry is possible and desirable and that explicit policies can clarify areas of ambiguity.</description><subject>Medical personnel</subject><subject>Medicine</subject><subject>Pharmaceutical industry</subject><subject>Physician relations</subject><subject>Public health</subject><subject>Study &amp; teaching</subject><subject>Training</subject><issn>0820-3946</issn><issn>1488-2329</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><recordid>eNotjk1LxDAYhIMoWFf_Q_BeyEeTpkdZP2HBi96EJU3ebLO0SU1SZf-9BXcuA8PDzFygijZK1Yyz7hJVRDFS866R1-gm5yNZxVlboa9H-IExzhOEgqPDCbK3EMwJzykekp7wYVmD0QfI2MWEfSiQtCk-Bvzry4DLAHgedJq0gaV4o8eVsUsu6XSLrpweM9ydfYM-n58-tq_17v3lbfuwq2eqSKmt00pT1lneO81M35pGOQFE9VZQZ0VnBZeU96o3mjpuO9UIwoURFKgELvkG3f_3rp-_F8hlf4xLCuvknpGmVa1Ukv8BhFRSUA</recordid><startdate>19930815</startdate><enddate>19930815</enddate><general>CMA Impact, Inc</general><scope>4T-</scope><scope>4U-</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>19930815</creationdate><title>Development of residency program guidelines for interaction with the pharmaceutical industry</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p180t-dfa8a129d3bfa2cb7c48f5e08bd51fd59d53613b8bca1f3d9845035c51e16e363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Medical personnel</topic><topic>Medicine</topic><topic>Pharmaceutical industry</topic><topic>Physician relations</topic><topic>Public health</topic><topic>Study &amp; teaching</topic><topic>Training</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><collection>Docstoc</collection><collection>University Readers</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Canadian Medical Association journal (CMAJ)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of residency program guidelines for interaction with the pharmaceutical industry</atitle><jtitle>Canadian Medical Association journal (CMAJ)</jtitle><date>1993-08-15</date><risdate>1993</risdate><volume>149</volume><issue>4</issue><spage>405</spage><pages>405-</pages><issn>0820-3946</issn><eissn>1488-2329</eissn><coden>CMAJAX</coden><abstract>Medical residency programs are likely to face increasing pressure to address their relations with the pharmaceutical industry. Our internal medicine residency program has developed guidelines that were adopted after extensive debate by residents and faculty members. The guidelines are based on the principles that residents and faculty should set the educational agenda and that the residency program should not allow gifts of any sort from industry to residents. Specific policies include obtaining and screening educational materials from the industry before residents are exposed to them, proscribing "drug lunches" and accepting industry sponsorship only when the residency program maintains complete control of the educational event being sponsored. The industry response to the guidelines was split; about half reacted negatively, and half found the guidelines acceptable. Our experience suggests that productive debate about guidelines for the interaction of residency programs with the pharmaceutical industry is possible and desirable and that explicit policies can clarify areas of ambiguity.</abstract><cop>Ottawa</cop><pub>CMA Impact, Inc</pub></addata></record>
fulltext fulltext
identifier ISSN: 0820-3946
ispartof Canadian Medical Association journal (CMAJ), 1993-08, Vol.149 (4), p.405
issn 0820-3946
1488-2329
language eng
recordid cdi_proquest_journals_204787686
source PubMed Central; Alma/SFX Local Collection
subjects Medical personnel
Medicine
Pharmaceutical industry
Physician relations
Public health
Study & teaching
Training
title Development of residency program guidelines for interaction with the pharmaceutical industry
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T15%3A46%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20residency%20program%20guidelines%20for%20interaction%20with%20the%20pharmaceutical%20industry&rft.jtitle=Canadian%20Medical%20Association%20journal%20(CMAJ)&rft.date=1993-08-15&rft.volume=149&rft.issue=4&rft.spage=405&rft.pages=405-&rft.issn=0820-3946&rft.eissn=1488-2329&rft.coden=CMAJAX&rft_id=info:doi/&rft_dat=%3Cproquest%3E450577461%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204787686&rft_id=info:pmid/&rfr_iscdi=true